| # | Title | Journal | Year | Citations |
|---|
| 1 | Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): an international, open-label, randomised, controlled, phase 3, multicentre trial | Lancet Oncology, The | 2017 | 370 |
| 2 | Prolonged lung cancer screening reduced 10-year mortality in the MILD trial: new confirmation of lung cancer screening efficacy | Annals of Oncology | 2019 | 328 |
| 3 | Neoadjuvant Chemotherapy in High-Risk Soft Tissue Sarcomas: Final Results of a Randomized Trial From Italian (ISG), Spanish (GEIS), French (FSG), and Polish (PSG) Sarcoma Groups | Journal of Clinical Oncology | 2020 | 145 |
| 4 | Pazopanib in advanced and platinum-resistant urothelial cancer: an open-label, single group, phase 2 trial | Lancet Oncology, The | 2012 | 130 |
| 5 | Clinical activity of androgen deprivation therapy in patients with metastatic/relapsed androgen receptor–positive salivary gland cancers | Head and Neck | 2016 | 104 |
| 6 | Low-dose computed tomography for lung cancer screening: comparison of performance between annual and biennial screen | European Radiology | 2016 | 92 |
| 7 | Short, full-dose adjuvant chemotherapy (CT) in high-risk adult soft tissue sarcomas (STS): long-term follow-up of a randomized clinical trial from the Italian Sarcoma Group and the Spanish Sarcoma Group | Annals of Oncology | 2016 | 90 |
| 8 | Imatinib in advanced chordoma: A retrospective case series analysis | European Journal of Cancer | 2015 | 78 |
| 9 | Ten-year results of the Multicentric Italian Lung Detection trial demonstrate the safety and efficacy of biennial lung cancer screening | European Journal of Cancer | 2019 | 72 |
| 10 | First‐line therapy with dacomitinib, an orally available pan‐HER tyrosine kinase inhibitor, for locally advanced or metastatic penile squamous cell carcinoma: results of an open‐label, single‐arm, single‐centre, phase 2 study | BJU International | 2018 | 70 |
| 11 | PF-03446962, a fully-human monoclonal antibody against transforming growth-factor β (TGFβ) receptor ALK1, in pre-treated patients with urothelial cancer: an open label, single-group, phase 2 trial | Investigational New Drugs | 2014 | 50 |
| 12 | Neoadjuvant chemotherapy in high‐risk soft tissue sarcomas: A Sarculator‐based risk stratification analysis of the ISG‐STS 1001 randomized trial | Cancer | 2022 | 46 |
| 13 | Baseline computed tomography screening and blood microRNA predict lung cancer risk and define adequate intervals in the BioMILD trial | Annals of Oncology | 2022 | 46 |
| 14 | Vascular resection en-bloc with tumor removal and graft reconstruction is safe and effective in soft tissue sarcoma (STS) of the extremities and retroperitoneum | Surgical Oncology | 2016 | 41 |
| 15 | Best practices for the management of thymic epithelial tumors: A position paper by the Italian collaborative group for ThYmic MalignanciEs (TYME) | Cancer Treatment Reviews | 2018 | 38 |
| 16 | Big Data in Head and Neck Cancer | Current Treatment Options in Oncology | 2018 | 38 |
| 17 | Correlation between radiological assessment and histopathological diagnosis in retroperitoneal tumors: Analysis of 291 consecutive patients at a tertiary reference sarcoma center | European Journal of Surgical Oncology | 2014 | 36 |
| 18 | Computed tomography-derived radiomic signature of head and neck squamous cell carcinoma (peri)tumoral tissue for the prediction of locoregional recurrence and distant metastasis after concurrent chemo-radiotherapy | PLoS ONE | 2020 | 35 |
| 19 | Assessment of Safety and Efficacy of Combined Trabectedin and Low-Dose Radiotherapy for Patients With Metastatic Soft-Tissue Sarcomas | JAMA Oncology | 2020 | 33 |
| 20 | Clinical and radiological features of brain neurotoxicity caused by antitumor and immunosuppressant treatments | Neurological Sciences | 2008 | 30 |
| 21 | MRI based radiomics in nasopharyngeal cancer: Systematic review and perspectives using radiomic quality score (RQS) assessment | European Journal of Radiology | 2021 | 30 |
| 22 | Baseline MRI-Radiomics Can Predict Overall Survival in Non-Endemic EBV-Related Nasopharyngeal Carcinoma Patients | Cancers | 2020 | 29 |
| 23 | The Activity of Chemotherapy in Inflammatory Myofibroblastic Tumors: A Multicenter, European Retrospective Case Series Analysis | Oncologist | 2020 | 27 |
| 24 | Pembrolizumab and nab-paclitaxel as salvage therapy for platinum-treated, locally advanced or metastatic urothelial carcinoma: interim results of the open-label, single-arm, phase II PEANUT study | Annals of Oncology | 2020 | 23 |
| 25 | Wilms tumor, medulloblastoma, and rhabdomyosarcoma in adult patients: lessons learned from the pediatric experience | Cancer and Metastasis Reviews | 2019 | 22 |
| 26 | An open-label, single-arm, phase 2 study of the Aurora kinase A inhibitor alisertib in patients with advanced urothelial cancer | Investigational New Drugs | 2016 | 21 |
| 27 | Clinical and immunologic responses in melanoma patients vaccinated with MAGE‐A3‐genetically modified lymphocytes | International Journal of Cancer | 2013 | 20 |
| 28 | Thoracic paravertebral anesthesia for percutaneous radiofrequency ablation of hepatic tumors | Journal of Clinical Anesthesia | 2014 | 20 |
| 29 | The Value of Multiparametric Magnetic Resonance Imaging Sequences to Assist in the Decision Making of Muscle-invasive Bladder Cancer | European Urology Oncology | 2021 | 20 |
| 30 | A feasibility study of preoperative pembrolizumab before radical nephroureterectomy in patients with high-risk, upper tract urothelial carcinoma: PURE-02 | Urologic Oncology: Seminars and Original Investigations | 2022 | 20 |
| 31 | MRI Characteristics of Pediatric Renal Tumors: A SIOP‐RTSG Radiology Panel Delphi Study | Journal of Magnetic Resonance Imaging | 2022 | 18 |
| 32 | Increased mean lung density: Another independent predictor of lung cancer? | European Journal of Radiology | 2013 | 17 |
| 33 | Analysis of plasma cytokines and angiogenic factors in patients with pretreated urothelial cancer receiving Pazopanib: the role of circulating interleukin-8 to enhance the prognostic accuracy | British Journal of Cancer | 2014 | 16 |
| 34 | Inoperable Primary Retroperitoneal Sarcomas: Clinical Characteristics and Reasons Against Resection at a Single Referral Institution | Annals of Surgical Oncology | 2021 | 16 |
| 35 | Low-dose CT for lung cancer screening: position paper from the Italian college of thoracic radiology | Radiologia Medica | 2022 | 16 |
| 36 | Double-Contrast Barium Enema and Computerised Tomography in the Pre-Operative Evaluation of Rectal Carcinoma: Are they Still Useful Diagnostic Procedures? | Tumori | 2000 | 13 |
| 37 | A proposal of an updated classification for pelvic relapses of rectal cancer to guide surgical decision‐making | Journal of Surgical Oncology | 2020 | 13 |
| 38 | A case of relapsing spinal atypical teratoid/rhabdoid tumor (AT/RT) responding to vinorelbine, cyclophosphamide, and celecoxib | Child's Nervous System | 2015 | 12 |
| 39 | Prognostic reclassification of patients with intermediate-risk metastatic germ cell tumors: Implications for clinical practice, trial design, and molecular interrogation | Urologic Oncology: Seminars and Original Investigations | 2015 | 12 |
| 40 | PL02.04 Blood MicroRNA and LDCT Reduce Unnecessary LDCT Repeats in Lung Cancer Screening: Results of Prospective BioMILD Trial | Journal of Thoracic Oncology | 2019 | 12 |
| 41 | Nutritional status and body composition assessment in patients with a new diagnosis of advanced solid tumour: Exploratory comparison of computed tomography and bioelectrical impedance analysis | Clinical Nutrition | 2021 | 12 |
| 42 | Impact of Pathological Stratification on the Clinical Outcomes of Advanced Well-Differentiated/Dedifferentiated Liposarcoma Treated with Trabectedin | Cancers | 2021 | 12 |
| 43 | Neoadjuvant (re)chemoradiation for locally recurrent rectal cancer: Impact of anatomical site of pelvic recurrence on long-term results | Surgical Oncology | 2020 | 10 |
| 44 | Improved Biopsy Accuracy in Retroperitoneal Dedifferentiated Liposarcoma | Annals of Surgical Oncology | 2020 | 10 |
| 45 | Treatment strategies and outcomes of primary Myxofibrosarcomas in a large patients cohort | European Journal of Surgical Oncology | 2022 | 10 |
| 46 | Completion surgery of residual disease after primary inadequate surgery of retroperitoneal sarcomas can salvage a selected subgroup of patients—A propensity score analysis | Journal of Surgical Oncology | 2019 | 9 |
| 47 | How we approach paediatric renal tumour core needle biopsy in the setting of preoperative chemotherapy: A Review from the SIOP Renal Tumour Study Group | Pediatric Blood and Cancer | 2022 | 9 |
| 48 | Neoadjuvant sorafenib, gemcitabine, and cisplatin administration preceding cystectomy in patients with muscle-invasive urothelial bladder carcinoma: An open-label, single-arm, single-center, phase 2 study | Urologic Oncology: Seminars and Original Investigations | 2018 | 8 |
| 49 | Outcome of SIOP patients with low- or intermediate-risk Wilms tumour relapsing after initial vincristine and actinomycin-D therapy only − the SIOP 93–01 and 2001 protocols | European Journal of Cancer | 2022 | 8 |
| 50 | The impact of radiomics for human papillomavirus status prediction in oropharyngeal cancer: systematic review and radiomics quality score assessment | Neuroradiology | 2022 | 8 |
